The British company DeepMind has revealed a large part of the solution to the problem of predicting how proteins fold in 3D to take shape, a shape that is crucial for determining their properties, including those for developing new drugs. This is all done with Artificial Intelligence algorithms, thus saving years of laboratory research (using techniques such as NMR or even synchrotron white light, which involves a particle accelerator). The score achieved by DeepMind’s AI (Deep Learning) is 90 on a 0-100 scale, comparable to the score achieved using laboratory techniques.
